ZERENEX™ (FERRIC CITRATE) FOR THE TREATMENT OF IRON-DEFICIENCY ANEMIA AND REDUCTION OF SERUM PHOSHATE IN NON-DIALYSIS DEPENDENT CKD

被引：0
|
作者：
Block, Geoffrey A. [1 ]
Fishbane, Steven [2 ]
Shemesh, Shay [3 ]
Sharma, Amit [3 ]
Chertow, Glenn M. [4 ]
机构：
[1] Denver Nephrol, Denver, CO USA
[2] Hofstra North Shore LIJ Sch Med, Great Neck, NY USA
[3] Keryx Inc, New York, NY USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2014年 / 63卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
400
引用
收藏
页码：A118 / A118
页数：1
相关论文
共 50 条
  • [1] A DOUBLE-BLIND PLACEBO CONTROLLED RANDOMIZED TRIAL OF FERRIC CITRATE COORDINATION COMPLEX FOR THE TREATMENT OF IRON-DEFICIENCY ANEMIA AND REDUCTION OF SERUM PHOSPHATE IN PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
    Block, Geoffrey
    Fishbane, Steven
    Shemesh, Shay
    Sharma, Amit
    Wolf, Myles
    Chertow, Glenn
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 151 - 151
  • [2] Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
    Fishbane, Steven
    Block, Geoffrey A.
    Loram, Lisa
    Neylan, John
    Pergola, Pablo E.
    Uhlig, Katrin
    Chertow, Glenn M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (06): : 1851 - 1858
  • [3] Ferric carboxymaltose for the treatment of iron-deficiency anemia
    Munoz, Manuel
    Martin-Montanez, Elisa
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (06) : 907 - 921
  • [4] DIFFERENT FERRIC CITRATE DOSE REGIMENS IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CKD: THE COMPASS TRIAL
    Pergola, Pablo
    Belo, Diogo
    Crawford, Paul
    Moustafa, Moustafa
    Vargo, Dennis
    Luo, Wenli
    Goldfarb-Rumyantezev, Alexander
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 56 - 56
  • [5] THE DIFFERENTIAL EFFECT OF THIRD-GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON HEMATINIC AND RENAL FUNCTION VARIABLES IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I379 - I380
  • [6] EFFICACY OF ORAL IRON FOR TREATING IRON DEFICIENCY IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD)
    Macdougall, I. C.
    Bock, A. H.
    Carrera, F.
    Eckardt, K-U
    Gaillard, C.
    Van Wyck, D.
    Meier, Y.
    Larroque, S.
    Perrin, A.
    Roger, S. D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [7] USE OF FERRIC CHOLINE CITRATE IN PREVENTION OF IRON-DEFICIENCY ANEMIA IN BABY PIGS
    SMITHWICK, GA
    VACIK, JP
    SCHIPPER, IA
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1967, 28 (123) : 469 - +
  • [8] PREDICTING SERUM BICARBONATE IN NON-DIALYSIS DEPENDENT CKD PATIENTS
    De la Torre-Quiroga, Andres
    Chavez-Iniguez, Jonathan S.
    Raimann, Jochen
    Cherif, Alhaji
    Moreno, Cynthia
    Maya Quinta, Rogelio de Jesus
    Kotanko, Peter
    Garcia-Garcia, Guillermo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I299 - I300
  • [9] THE DIFFERENTIAL EFFECT OF THIRD-GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON CARDIOVASCULAR PARAMETERS IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANAEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I385 - I385
  • [10] FERRIC CITRATE INCREASES HEMOGLOBIN IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA.
    Pergola, P. E.
    Fishbane, S.
    Neylan, J. F.
    Uhlig, K.
    Chertow, G. M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (04) : A76 - A76
12345